Bluebird Botanicals, per cbdMD’s release, is one of the longest-standing brands in the CBD industry. Since January it has belonged to cbdMD.
Updated 7 November 2026: details are re-sourced to primary documents, and lines with no primary document are cut.
Updated 6 November 2026: the score is removed; this is now an assessment of published documents.
cbdMD announced the closing of the acquisition on January 14, 2026 — an all-equity asset purchase: an initial share issuance plus earnout shares. The catalog and the batch portal are still there. The copyright line under them names a different company.
The facts, up front
Read the footer first
The contact block and copyright line on the storefront now read BB Botanicals, LLC, Louisville, CO. cbdMD’s quarterly report for the period ended March 31 gives that name to the subsidiary it calls Bluebird, and puts total purchase consideration at $936,992.
cbdMD’s August 13 quarterly release reports net sales of $5.6 million for the quarter, up 20% year over year, and says Bluebird contributed its first full quarter of revenue. The release is the company’s own statement.
The lab portal, opened first
The COA page is a batch lookup: type the lot number, get that lot’s PDF. That ties your bottle to its own report, not a sample from an earlier run.
What it doesn’t do is name the lab or the panels. The site-wide footnote credits “third-party HPLC analysis,” and HPLC is a potency method. Pull your own batch sheet and look past the cannabinoid table to the contaminant panels.
The price list, done properly
Start with what isn’t there. On the four oil pages I opened on September 3 — Classic, Complete, THC Free Signature and the isolate — none printed a total CBD figure for the bottle. Every cent-per-milligram below is derived, not quoted.
You build it from the label: 25 mg in a 0.5 mL serving — the page caps you at two of them, 1 mL, a day — and roughly 30 mL to the ounce. Sixty servings to the ounce: 1,500 mg in a 1 oz bottle, 3,000 mg in a 2 oz.
On that arithmetic the THC Free Signature 2 oz at $109.95 lands near 3.7 cents a milligram, and the 1 oz isolate at $54.95 the same. Classic CBD Oil at 25 mg per serving, 1 oz, $104.95 works out near 7.0 cents. Complete CBDA + CBD at that size, $114.95, is about 7.7 cents; the 2 oz Complete at $204.95, roughly 6.8.
So the products this brand is known for cost between roughly 1.4 and 2.1 times per milligram what its broad-spectrum bottle does; like for like at 2 oz, Classic 25 mg runs near 6.0 cents and Classic 10 mg near 5.0. Stock is patchier than the price list suggests: across those four oils plus the Organic tincture, three SKUs were showing sold out on September 3 — the 25 mg 2 oz Classic, the 1 oz isolate and the 1 oz Organic. The cheapest full-spectrum rung, Classic 10 mg at 2 oz for $59.95, was buyable.
One caution: a site-wide banner today advertises a Labor Day sale at 50% off, the newsletter box 40% off a first order. Every figure above is the signed-out list price.
The number that matters, and its new date
The date moved yesterday. The President signed the continuing resolution on September 2, and per trade reporting on its hemp provisions that pushes the 0.4 mg per-container limit and the total-THC standard from November 12 to December 11. One piece does not move: cannabinoids the plant cannot produce on its own still lose hemp status on November 12. The slip we flagged last month is now law. Four extra weeks, not a reprieve.
The test itself is unchanged: 0.4 mg of total THC per container, a milligram budget for the whole bottle, not a percentage. Bluebird states its own ceiling in that unit: at 25 mg a serving, Classic and Complete both give total THC as no more than 57 mg per 1 oz container and 114 mg per 2 oz.
Credit for the right unit; read the size of it anyway. A ceiling is not a measurement, and it sits far above the coming budget. The footer’s standing line about “less than 0.3% THC, in compliance with federal regulations” is the old percentage test.
And on the Signature, the broad-spectrum oil: its THC disclosure reads “0.01% mg per serving” — a unit that does not exist — and carries no per-container figure. The isolate does print one, at no more than 1.2 mg per 1 oz container — the closest of these four oils to the 0.4 mg budget, and still three times over it.
Pros and cons
Our assessment
This is an assessment of published documents about the brand: a cbdMD press release on the January 2026 acquisition, the retailer’s own listed prices and per-container THC ceilings, and the shift of the federal hemp definition date to December 11, 2026.
Buy the broad-spectrum, or buy on the assistance program. The Signature 2 oz works out to the cheapest milligram on the shelf and was in stock on September 3; the Assistance Program’s 50% off — documents by email, a code in seven to ten business days — is deep enough to change who can afford the category. If raw-plus-heated CBDA is what you came for, Complete is worth its premium; do the division first.
The B Corp mark is a private certification, not any government’s approval — and nothing here carries one of those: the FDA has evaluated none of these products, none is intended to diagnose, treat, cure or prevent any disease, and the site’s own footer puts the floor at 21.
Documents read
Read on 6 November 2026:
-
cbdMD press release, Bluebird acquisition (14 Jan 2026): cbdMD announced closing of the acquisition of substantially all assets of Bluebird Botanicals on 14 Jan 2026; asset purchase of an initial share issuance and earnout shares.
-
White House notice, H.R. 6500 signed (2 Sep 2026): President signed H.R. 6500, Continuing Appropriations and Extensions Act, 2027, on 2 September 2026, funding agencies through 11 December 2026. No mention of hemp.
-
CRS In Focus IF13136, definition of hemp: The new hemp definition was due to take effect 12 November 2026; after P.L. 119-103 the effective date for portions of the definition is delayed to 11 December 2026.
-
cbdMD Form 10-Q, quarter ended March 31, 2026: BB Botanicals, a North Carolina limited liability company, called Bluebird; total purchase consideration $936,992 for the Bluebird asset acquisition. Read through a text .
-
cbdMD third fiscal quarter 2026 results release (13 Aug 2026): Net sales up 20% to $5.6 million versus $4.6 million, quarter ended 30 June 2026, and the first full quarter of contribution from Bluebird Botanicals; no dollar figure fo.